Literature DB >> 28437849

Clinical significance of IgE in a large cohort of patients with moderate or severe chronic graft-versus-host disease.

Sencer Goklemez1,2, Filip Pirsl1, Lauren M Curtis1, Seth M Steinberg3, Edward W Cowen4, Jacqueline W Mays5, Meg Kenyon1, Judy Baruffaldi1, Fran T Hakim1, Steven Z Pavletic1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28437849      PMCID： PMC5551423          DOI： 10.1002/ajh.24768

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  6 in total

1.  National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report.

Authors:  Alexandra H Filipovich; Daniel Weisdorf; Steven Pavletic; Gerard Socie; John R Wingard; Stephanie J Lee; Paul Martin; Jason Chien; Donna Przepiorka; Daniel Couriel; Edward W Cowen; Patricia Dinndorf; Ann Farrell; Robert Hartzman; Jean Henslee-Downey; David Jacobsohn; George McDonald; Barbara Mittleman; J Douglas Rizzo; Michael Robinson; Mark Schubert; Kirk Schultz; Howard Shulman; Maria Turner; Georgia Vogelsang; Mary E D Flowers
Journal:  Biol Blood Marrow Transplant       Date:  2005-12       Impact factor: 5.742

2.  Upregulation of IFN-Inducible and Damage-Response Pathways in Chronic Graft-versus-Host Disease.

Authors:  Frances T Hakim; Sarfraz Memon; Ping Jin; Matin M Imanguli; Huan Wang; Najibah Rehman; Xiao-Yi Yan; Jeremy Rose; Jacqueline W Mays; Susan Dhamala; Veena Kapoor; William Telford; John Dickinson; Sean Davis; David Halverson; Haley B Naik; Kristin Baird; Daniel Fowler; David Stroncek; Edward W Cowen; Steven Z Pavletic; Ronald E Gress
Journal:  J Immunol       Date:  2016-09-30       Impact factor: 5.422

Review 3.  Are increased IgE-levels a signal of an acute graft-versus-host reaction?

Authors:  O Ringdén; U Persson; S G Johansson
Journal:  Immunol Rev       Date:  1983       Impact factor: 12.988

4.  Pathogenicity of IgE in autoimmunity: successful treatment of bullous pemphigoid with omalizumab.

Authors:  Janet A Fairley; Christian L Baum; Debra S Brandt; Kelly A N Messingham
Journal:  J Allergy Clin Immunol       Date:  2009-01-18       Impact factor: 10.793

Review 5.  The Biology of Chronic Graft-versus-Host Disease: A Task Force Report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease.

Authors:  Kenneth R Cooke; Leo Luznik; Stefanie Sarantopoulos; Frances T Hakim; Madan Jagasia; Daniel H Fowler; Marcel R M van den Brink; John A Hansen; Robertson Parkman; David B Miklos; Paul J Martin; Sophie Paczesny; Georgia Vogelsang; Steven Pavletic; Jerome Ritz; Kirk R Schultz; Bruce R Blazar
Journal:  Biol Blood Marrow Transplant       Date:  2016-10-03       Impact factor: 5.742

6.  Autoreactive IgE is prevalent in systemic lupus erythematosus and is associated with increased disease activity and nephritis.

Authors:  Barbara Dema; Christophe Pellefigues; Sarfaraz Hasni; Nathalie Gault; Chao Jiang; Tiffany K Ricks; Michael M Bonelli; Jörg Scheffel; Karim Sacré; Mathieu Jablonski; Delphine Gobert; Thomas Papo; Eric Daugas; Gabor Illei; Nicolas Charles; Juan Rivera
Journal:  PLoS One       Date:  2014-02-28       Impact factor: 3.240
  6 in total
  2 in total

Review 1.  Mast Cell Involvement in Fibrosis in Chronic Graft-Versus-Host Disease.

Authors:  Ethan Strattan; Gerhard Carl Hildebrandt
Journal:  Int J Mol Sci       Date:  2021-02-27       Impact factor: 5.923

2.  National Institutes of Health-Defined Chronic Graft-vs.-Host Disease in Pediatric Hematopoietic Stem Cell Transplantation Patients Correlates With Parameters of Long-Term Immune Reconstitution.

Authors:  Anita Lawitschka; Ece Dila Gueclue; Angela Januszko; Ulrike Körmöczi; Arno Rottal; Gerhard Fritsch; Dorothea Bauer; Christina Peters; Hildegard T Greinix; Winfried F Pickl; Zoya Kuzmina
Journal:  Front Immunol       Date:  2019-08-27       Impact factor: 7.561
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.